Low-dose Apalutamide in Non-metastatic Castration-resistant Prostate Cancer: A Case Series
Low-dose apalutamide was effective in this 6-patient case series. While awaiting new dose-response studies, we propose an apalutamide dose prescription flowchart that can be adapted for individual patients to avoid exposure to higher doses of the drug.
Authors
- Nguyen Minh Dung (ORCID: https://orcid.org/0000-0002-0662-1786)
- Olena Gorobets (ORCID: https://orcid.org/0000-0003-2589-092X)
- Claire F. Verschraegen (ORCID: https://orcid.org/0000-0001-6544-3089)
- Vincent Vinh‐Hung (ORCID: https://orcid.org/0000-0002-6403-6120)
- Johan Rose Dite Modestine
- YANNICK JOEL DJOUA
Institutions
- Centre Hospitalier de Perpignan (FR)
- Centre Hospitalier Universitaire de Martinique (MQ)
- Centre Hospitalier Public du Cotentin (FR)
Publication Details
- Journal
- Anticancer Research
- Published
- 2025-06-27
- DOI
- https://doi.org/10.21873/anticanres.17676
- Primary Topic
- Prostate Cancer Treatment and Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Bristol-Myers Squibb
- Pfizer
- AstraZeneca
- Sanofi
- MSD France
- Ipsen
- Cilag